Back to Journals » Infection and Drug Resistance » Volume 12

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Total article views   HTML views PDF downloads Totals
7,811 Dovepress* 7,260+ 1,664 8,924
PubMed Central* 551 216 767
Totals 7,811 1,880 9,691
*Since 1 April 2019

View citations on PubMed Central and Google Scholar